COVID-19’s Impact On Diagnostics

Written by
May 15, 2020

Due to fears over COVID-19, fewer people are being evaluated for signs of stroke, according to a recent study from Washington University School of Medicine. A King’s College London, Massachusetts General Hospital, and ZOE team-developed AI diagnostic may predict whether someone has COVID-19 based on symptoms. An amended emergency use authorization from the FDA for thefirst at-home saliva collection test forSARS-CoV-2 from RUCDR Infinite Biologics. We round up the week’s research and industry news for COVID-19.READ MORE

Press inquires
pr@genalyte.com